US FDA Emergency Use Authorization (EUA) Meeting Schedule

14:00GMT/09:00EST - Opening Remarks: Call to Order and Welcome
14:30GMT/09:30EST - FDA Presentation on Emergency Use Authorization
15:00GMT/10:00EST - Update on Epidemiology (10 min) + Q&A
15:30GMT/10:30EST - Vaccine Safety and Effectiveness Monitoring (15 min) + Q&A
15:50GMT/10:50EST - Considerations for placebo-controlled trial design if an unlicensed vaccine becomes available (20 min) + Q&A
19:00GMT/14:00EST - FDA Presentation and Voting Questions (50 min) + Q&A
20:10GMT/15:10EST - Committee Discussion and Voting (125 min)
Link to full schedule